OT Research

RIASEC RegisteredEst. 2020
Total AUM
$1.6B
Discretionary
$1.6B
100% of AUM
Avg account
$194M
Accounts
8
Employees
11
Advisory reps
3

Firm details

Headquarters
,
CRD number
299086
Registered since
September 22, 2020
Custodians
GOLDMAN SACHS & CO. LLC
Fee structure
Percentage of AUM, Performance Based Fees
Client types
  • Pooled Investment Vehicles55.6%
  • Investment Companies35.97%
  • Other Investment Advisers8.43%
Services
Portfolio Management for Investment CompaniesPortfolio Management for Pooled Investment Vehicles

Firm profile

FINTRX

Overview

OT Research is a U.S. limited liability company operating as a hedge fund adviser that registered with the SEC in 2020. The firm serves institutional clients and functions as a commodity pool operator/commodity trading adviser while also providing portfolio management for investment companies and pooled investment vehicles. Its compensation combines asset-based fees with performance-linked fees, consistent with an active manager running both public and pooled strategies. OT Research does not characterize itself as an ESG investor and is not registered as a multi-state adviser.

Assets & Accounts

Public Holdings

Investments & Alternatives

Location & Offices

Investment profile

FINTRX

Traditional investments used

Alternative investments used

Active ESG investor

Technology & operations

FINTRX

CRM & tech providers

TAMPs used

Clients

FINTRX

Client base

Client personas

Asset composition

Asset composition: Exchange Traded Equities 100%100%
  • Exchange Traded Equities100%

Owners & executives

1 of 1
  • Julie Wilson

    Julie Wilson

    CCO & COOCRD 7150107

Contacts

2 of 2
  • Rishi Narang

    Rishi Narang

    Elected ManagerCRD 2846083

  • David Hensle

    David Hensle

    ManagerCRD 4693342

Wealth teams

FINTRX

Newly hired reps

FINTRX

Recent M&A activity

FINTRX

Recent filings

FINTRX

Awards

FINTRX

Location

Primary office

, null

Location

, null

Headquartered in , null.

Office locations

Similar firms

Source: FINTRX private wealth data intelligence

Intelligence for Private Wealth